Bill Text: HI SB2216 | 2018 | Regular Session | Introduced
Bill Title: Relating To Medical Cannabis.
Spectrum: Partisan Bill (Democrat 5-0)
Status: (Introduced - Dead) 2018-01-30 - Re-Referred to CPH, JDC/WAM. [SB2216 Detail]
Download: Hawaii-2018-SB2216-Introduced.html
|
THE SENATE |
S.B. NO. |
2216 |
|
TWENTY-NINTH LEGISLATURE, 2018 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
relating to medical cannabis.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Chapter 431, Hawaii Revised Statutes, is amended by adding a new section to article 10A to be appropriately designated and to read as follows:
"§431:10A- Medical
cannabis; manufactured cannabis products; qualifying patients; reimbursement;
limits. (a) A qualifying patient who obtains medical
cannabis or manufactured cannabis products pursuant to part IX of chapter 329
and chapter 329D shall be eligible for reimbursement as follows:
(1) A qualifying
patient shall be eligible for a dollar-for-dollar reimbursement on any amount
between $100 and $150 that is spent per month on medical cannabis or
manufactured cannabis products, for a maximum monthly reimbursement of $50;
(2) Monthly amounts
in excess of $150 that are spent by a qualifying patient on medical cannabis or
manufactured cannabis products shall be covered entirely by the patient and
shall not be eligible for reimbursement under this section; and
(3) A qualifying
patient shall be limited to a yearly maximum of $600 in reimbursements.
(b) Health insurers shall establish a system to
reimburse qualifying patients pursuant to this section on at least a quarterly
basis.
(c) For purposes of this section:
"Manufactured cannabis
product" shall have the same meaning as in section 329D-1.
"Medical cannabis" shall
have the same meaning as in section 329-121.
"Qualifying patient" shall have the same meaning as in section 329-121."
SECTION 2. Chapter 432, Hawaii Revised Statutes, is amended by adding a new section to article 1 to be appropriately designated and to read as follows:
"§432:1- Medical
cannabis; manufactured cannabis products; qualifying patients; reimbursement;
limits. (a) A qualifying patient who obtains medical
cannabis or manufactured cannabis products pursuant to part IX of chapter 329
and chapter 329D shall be eligible for reimbursement as follows:
(1) A qualifying
patient shall be eligible for a dollar-for-dollar reimbursement on any amount
between $100 and $150 that is spent per month on medical cannabis or
manufactured cannabis products, for a maximum monthly reimbursement of $50;
(2) Monthly amounts
in excess of $150 that are spent by a qualifying patient on medical cannabis or
manufactured cannabis products shall be covered entirely by the patient and
shall not be eligible for reimbursement under this section; and
(3) A qualifying
patient shall be limited to a yearly maximum of $600 in reimbursements.
(b) Mutual benefit societies shall establish a
system to reimburse qualifying patients pursuant to this section on at least a
quarterly basis.
(c) For purposes of this section:
"Manufactured cannabis
product" shall have the same meaning as in section 329D-1.
"Medical cannabis" shall
have the same meaning as in section 329-121.
"Qualifying patient" shall have the same meaning as in section 329-121."
SECTION 3. Chapter 432D, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:
"§432D- Medical
cannabis; manufactured cannabis products; qualifying patients; reimbursement;
limits. (a) A qualifying patient who obtains medical
cannabis or manufactured cannabis products pursuant to part IX of chapter 329
and chapter 329D shall be eligible for reimbursement as follows:
(1) A qualifying
patient shall be eligible for a dollar-for-dollar reimbursement on any amount
between $100 and $150 that is spent per month on medical cannabis or
manufactured cannabis products, for a maximum monthly reimbursement of $50;
(2) Monthly amounts
in excess of $150 that are spent by a qualifying patient on medical cannabis or
manufactured cannabis products shall be covered entirely by the patient and
shall not be eligible for reimbursement under this section; and
(3) A qualifying
patient shall be limited to a yearly maximum of $600 in reimbursements.
(b) Health maintenance organizations shall establish
a system to reimburse qualifying patients pursuant to this section on at least
a quarterly basis.
(c) For purposes of this section:
"Manufactured cannabis
product" shall have the same meaning as in section 329D-1.
"Medical cannabis" shall
have the same meaning as in section 329-121.
"Qualifying patient" shall have the same meaning as in section 329-121."
SECTION 4. New statutory material is underscored.
SECTION 5. This Act shall take effect upon its approval.
|
INTRODUCED BY: |
_____________________________ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Report Title:
Medical Cannabis; Manufactured Cannabis Product; Qualifying Patients; Reimbursement; Insurance
Description:
Permits qualifying patients to be reimbursed by health insurers, mutual benefit societies, and health maintenance organizations for amounts spent on medical cannabis and manufactured cannabis products. Limits the monthly amount of reimbursement.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.
